CST6 and breast cancer: Analysis of patients suffering from TNBC (10–20% of human ductal adenocarcinomas), which is the most aggressive breast cancer type, with the poorest prognosis and highest mortality rates, demonstrated that cystatin M/E was unexpectedly elevated in TNBC tissues vs. adjacent normal breast tissues.